Literature DB >> 2152777

Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.

I J Cook1, E J Irvine, D Campbell, S Shannon, S N Reddy, S M Collins.   

Abstract

The aims of this study were to determine (a) whether dietary fiber supplements modify symptoms in patients with irritable bowel syndrome, (b) the effect of fiber on rectosigmoid pressures, and (c) the relationship, if any, between rectosigmoid pressure and symptoms. Fourteen patients entered and 9 completed a double-blind, controlled, cross-over study of 7 mo duration. The mean age was 26 yr (range, 18-37). Patients received 4 cookies daily containing 20 mg corn fiber or placebo. Symptoms and compliance were evaluated monthly. Rectosigmoid pressures and dietary intake were evaluated at the outset and completion of each study arm. Symptoms improved during both fiber and placebo treatments. Those symptoms demonstrating significant improvement with time were pain severity, stool frequency, stool consistency (p = 0.001), number of additional gastrointestinal symptoms present (p = 0.02), and total symptom score (p less than 0.001). Rectosigmoid pressures were not significantly altered by fiber or placebo. Fasting pressures at the distal recording site tended to correlate with pain severity (r = 0.6; p = 0.06). It was concluded that (a) corn fiber and placebo were both effective in alleviating symptoms, (b) there was a correlation between symptom severity and fasting rectosigmoid pressure, and (c) there was a trend toward reduction in fasting and postprandial rectosigmoid pressures after fiber therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2152777     DOI: 10.1016/0016-5085(90)91292-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

2.  Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopeptides on bone metabolism in healthy, postmenopausal women.

Authors:  Berit Adolphi; Katharina E Scholz-Ahrens; Michael de Vrese; Yahya Açil; Christiane Laue; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2008-11-21       Impact factor: 5.614

Review 3.  Current views on the aetiology and management of the irritable bowel syndrome.

Authors:  M J Hall; R E Barry
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 4.  Treatment of irritable bowel syndrome: a review of randomised controlled trials.

Authors:  R Akehurst; E Kaltenthaler
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 5.  Drug treatment options for irritable bowel syndrome: managing for success.

Authors:  R C Dunphy; G N Verne
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Changes in intraluminal pressure in rat large intestines with aging and effects of dietary fiber.

Authors:  H Murakami; S Iwane; A Munakata; S Nakaji; K Sugawara; S Tsuchida; D Sasaki
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

7.  Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study.

Authors:  Hye-Kyung Jung; Rok Seon Choung; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-10-27       Impact factor: 10.864

Review 8.  Evaluation of drug treatment in irritable bowel syndrome.

Authors:  Nicholas J Talley
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

Review 9.  Updates on treatment of irritable bowel syndrome.

Authors:  Christopher W Hammerle; Christina M Surawicz
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

10.  High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).

Authors:  G C Parisi; M Zilli; M P Miani; M Carrara; E Bottona; G Verdianelli; G Battaglia; S Desideri; A Faedo; C Marzolino; A Tonon; M Ermani; G Leandro
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.